Encompass Health Corporation (NYSE:EHC) Stake Lessened by Madison Asset Management LLC

Madison Asset Management LLC lowered its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 5.6% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 82,974 shares of the company's stock after selling 4,933 shares during the quarter. Madison Asset Management LLC owned 0.08% of Encompass Health worth $8,404,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of EHC. T. Rowe Price Investment Management Inc. purchased a new position in Encompass Health during the 4th quarter worth $152,953,000. Norges Bank purchased a new position in Encompass Health during the 4th quarter worth $100,637,000. Farallon Capital Management LLC increased its holdings in shares of Encompass Health by 15,266.7% in the 4th quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock valued at $42,573,000 after purchasing an additional 458,000 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Encompass Health by 136.8% in the 4th quarter. AQR Capital Management LLC now owns 689,206 shares of the company's stock valued at $63,648,000 after purchasing an additional 398,154 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of Encompass Health by 22.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,610,669 shares of the company's stock valued at $148,746,000 after purchasing an additional 300,386 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Trading Up 0.4%

EHC stock traded up $0.40 during midday trading on Friday, reaching $107.53. 675,621 shares of the company's stock traded hands, compared to its average volume of 1,004,874. The company has a market capitalization of $10.84 billion, a P/E ratio of 22.22, a PEG ratio of 2.17 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a fifty-two week low of $82.74 and a fifty-two week high of $123.13. The business has a 50-day moving average price of $117.99 and a two-hundred day moving average price of $107.40.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. Encompass Health's revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.12 earnings per share. Equities research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.71%. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. Encompass Health's payout ratio is 15.70%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Royal Bank Of Canada increased their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a report on Monday, April 28th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target for the company in a report on Thursday, June 5th. Barclays increased their price target on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. KeyCorp raised their target price on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. Finally, Truist Financial restated a "buy" rating and set a $135.00 target price (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Seven analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average price target of $131.50.

Insider Activity

In other news, EVP John Patrick Darby sold 10,000 shares of the company's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the transaction, the executive vice president directly owned 79,710 shares in the company, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the sale, the chief executive officer directly owned 527,070 shares of the company's stock, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 132,663 shares of company stock worth $16,034,082 over the last 90 days. Company insiders own 2.00% of the company's stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.